128 related articles for article (PubMed ID: 29346782)
1. A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in Liver Transplantation for Hepatocellular Carcinoma.
Pinto-Marques H; Silva S; Sobral M; Perdigoto R; Martins A; Barroso E
Dig Surg; 2018; 35(6):539-548. PubMed ID: 29346782
[TBL] [Abstract][Full Text] [Related]
2. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
[TBL] [Abstract][Full Text] [Related]
3. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma.
Toso C; Trotter J; Wei A; Bigam DL; Shah S; Lancaster J; Grant DR; Greig PD; Shapiro AM; Kneteman NM
Liver Transpl; 2008 Aug; 14(8):1107-15. PubMed ID: 18668667
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
5. A Simple Measure of Hepatocellular Carcinoma Burden Predicts Tumor Recurrence After Liver Transplantation: The Recurrent Hepatocellular Carcinoma-Initial, Maximum, Last Classification.
Vutien P; Dodge J; Bambha KM; Nordstrom EM; Gralla J; Campbell K; Levek C; Nydam T; Fix O; Ioannou G; Biggins SW
Liver Transpl; 2019 Apr; 25(4):559-570. PubMed ID: 30706653
[TBL] [Abstract][Full Text] [Related]
6. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
Toso C; Meeberg G; Hernandez-Alejandro R; Dufour JF; Marotta P; Majno P; Kneteman NM
Hepatology; 2015 Jul; 62(1):158-65. PubMed ID: 25777590
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
Agopian VG; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Cheng EY; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2017 Jan; 152(1):55-64. PubMed ID: 27706479
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer.
Grat M; Kornasiewicz O; Hołówko W; Lewandowski Z; Zieniewicz K; Paczek L; Krawczyk M
Transplant Proc; 2013 Jun; 45(5):1899-903. PubMed ID: 23769067
[TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Aravinthan AD; Bruni SG; Doyle AC; Thein HH; Goldaracena N; Issachar A; Lilly LB; Selzner N; Bhat M; Sreeharsha B; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Greig PD; Renner EL; Grant DR; Sapisochin G
Ann Surg Oncol; 2017 Jul; 24(7):1843-1851. PubMed ID: 28160137
[TBL] [Abstract][Full Text] [Related]
10. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
[TBL] [Abstract][Full Text] [Related]
11. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
[TBL] [Abstract][Full Text] [Related]
14. Survival after Liver Transplant: Influence of Progression of Disease and of Restoration of the "Milan" Criteria in Patients with Hepato-cellular Carcinoma undergoing Down-staging Procedures.
Giacomoni A; Di Sandro S; Donadon M; Lauterio A; Belli L; Mangoni I; Mihaylov P; Concone G; De Carlis L
Hepatogastroenterology; 2015 Jun; 62(140):955-61. PubMed ID: 26902036
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
[TBL] [Abstract][Full Text] [Related]
16. Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study.
Piñero F; Costa P; Boteon YL; Duque SH; Marciano S; Anders M; Varón A; Zerega A; Poniachik J; Soza A; Machaca MP; Menéndez J; Zapata R; Vilatoba M; Muñoz L; Maraschio M; Fauda M; McCormack L; Gadano A; Boin IS; García JHP; Silva M
Ann Hepatol; 2018 Mar; 17(2):256-267. PubMed ID: 29469048
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Successful Downstaging of Hepatocellular Carcinoma Outside Milan Criteria.
Murali AR; Romero-Marrero C; Miller C; Aucejo F; Levitin A; Gill A; McLennan G; Karuppasamy K; Zein NN; Lopez R; Menon KV
Transplantation; 2016 Nov; 100(11):2391-2397. PubMed ID: 27780187
[TBL] [Abstract][Full Text] [Related]
19. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.
Toso C; Asthana S; Bigam DL; Shapiro AM; Kneteman NM
Hepatology; 2009 Mar; 49(3):832-8. PubMed ID: 19152426
[TBL] [Abstract][Full Text] [Related]
20. The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.
Grąt M; Wronka KM; Stypułkowski J; Bik E; Krasnodębski M; Masior Ł; Lewandowski Z; Grąt K; Patkowski W; Krawczyk M
Ann Surg Oncol; 2017 Feb; 24(2):526-534. PubMed ID: 27531306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]